Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06965166 · ClinicalTrials.gov registry record
Contrast-Enhanced Photon-Counting Detector CT (PCD-CT) for the Local Staging of Rectal Cancer
A clinical trial of Rectal Carcinoma, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- 120
- Enrollment target
- 1
- Study location
NCT06965166 is a study of Rectal Carcinoma that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 120 participants, below the 31,020-participant average among 5 other Rectal Carcinoma trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06965166, a study of Rectal Carcinoma, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
This study evaluates whether images taken using a photon counting detector CT scanner (PCD-CT) can determine the growth of rectal cancer as well as, or better than, MRI for the management of patients with rectal cancer.
Conditions Studied
Interventions
- PROCEDURE PCD-CT
Study Locations (1)
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2024-10-07 |
| Est. Completion | 2026-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06965166
The ClinicalTrials.gov registry entry for NCT06965166 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 31,020-participant average among 5 other Rectal Carcinoma trials with a reported enrollment target (100% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Rectal Carcinoma appearing as the primary indexed condition, and to 1 intervention - of which PCD-CT is the first listed.
NCT06965166 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT06965166 about?
NCT06965166 is a clinical study titled "Contrast-Enhanced Photon-Counting Detector CT (PCD-CT) for the Local Staging of Rectal Cancer". This study evaluates whether images taken using a photon counting detector CT scanner (PCD-CT) can determine the growth of rectal cancer as well as, or better than, MRI for the management of patients with rectal cancer.
What is the current status of trial NCT06965166?
This trial is currently recruiting. The enrollment target is 120 participants. The study started on 2024-10-07. Estimated completion is 2026-12-31.
What conditions does trial NCT06965166 study?
This clinical trial studies the following conditions: Rectal Carcinoma.
What interventions are being tested in trial NCT06965166?
The interventions under investigation include: PCD-CT (PROCEDURE).
Who is sponsoring clinical trial NCT06965166?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06965166 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Rectal Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Bowel Management Program (Retrograde Rectal Enema) for the Treatment of Low Anterior Resection Syndrome in Rectal Cancer Patients
RECRUITING · NA
-
Vaginal DHEA to Improve Vaginal Health After Radiation for Women With Gynecologic, Anal or Rectal Cancer
RECRUITING · Phase 2
-
Screening for Colorectal Cancer in Older Patients (PLCO Screening Trial)
ACTIVE NOT RECRUITING · NA
-
Changes in Pelvic Health, Sexual Function, and Quality of Life in Women With Pelvic Cancer Undergoing Radiation Therapy
ACTIVE NOT RECRUITING
-
PET/MRI as a Predictor of Response to Pre-op Chemoradiation in Resectable Rectal Cancer: a Pilot Study
COMPLETED
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.